Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | STS | P08842 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22005789 | 0.97 | DPP4 (0.47) | DPP4NPC1RAB9APOLBTSHR | |
| SCHEMBL414198 | 0.95 | NPC1 (0.52) | DPP4NPC1RAB9APOLBRAPGEF4 | |
| Phosphonic Acid SCHEMBL11425732 | 0.87 | NPC1 (0.47) | DPP4NPC1RAB9APOLBALDH1A1 | |
| Acetic Acid SCHEMBL27990190 | 0.83 | NPC1 (0.56) | NPC1RAB9APOLBALDH1A1SMN1; SMN2 | |
| SCHEMBL5905931 | 0.81 | CYP11B1 (0.50) | DPP4NPC1RAB9APOLBTSHR | |
| SCHEMBL17037968 | 0.81 | METAP1 (0.44) | DPP4NPC1RAB9APOLBALDH1A1 | |
| SCHEMBL15957848 | 0.80 | PNMT (0.46) | ADRA2AADRA2BADRA2C | |
| SCHEMBL6905898 | 0.79 | ALDH1A1 (0.47) | NPC1RAB9APOLBALDH1A1SMN1; SMN2 | |
| SCHEMBL28692154 | 0.78 | CYP2A6 (0.59) | DPP4NPC1RAB9APOLBALDH1A1 | |
| SCHEMBL10177007 | 0.78 | METAP1 (0.46) | DPP4NPC1RAB9APOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117871743-A | Method for simultaneously measuring residual amounts of 8 naphthalene compounds in recovered PET | 广州海关技术中心 | 2024-04-12 | — | — | CN | claimed |
| US-11637257-B2 | Electroluminescent material ink and electroluminescent device thereof | GUANGDONG JUHUA PRINTED DISPLAY TECHNOLOGY CO. LTD (CN) | 2023-04-25 | — | — | US | claimed |
| US-20220152587-A1 | JUTE STEM-SUPPORTED PALLADIUM-NPS AND USE AS DIP-CATALYSTS FOR AQUEOUS TRANSFER HYDROGENATION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2022-05-19 | — | — | US | claimed |
| CN-109929328-B | Composite ink and preparation method and device thereof | TCL科技集团股份有限公司 | 2021-10-22 | — | — | CN | claimed |
| US-20200373508-A1 | ELECTROLUMINESCENT MATERIAL INK AND ELECTROLUMINESCENT DEVICE THEREOF | GUANGDONG JUHUA PRINTED DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-11-26 | — | — | US | claimed |
| CN-108948865-B | Electroluminescent material ink and electroluminescent device thereof | 广东聚华印刷显示技术有限公司 | 2020-07-10 | — | — | CN | claimed |
| EP-1220852-B1 | SUBSTITUTED DIAZEPANS | NOVARTIS AG (CH) | 2006-01-18 | — | — | EP | claimed |
| EP-1220852-A1 | SUBSTITUTED DIAZEPANS | Novartis AG (CH) | 2002-07-10 | — | — | EP | claimed |
| US-6399599-B1 | ANTIINFLAMMATOY AGENTS; AUTOIMMUNE DISEASE | NOVARTIS AG (CH) | 2002-06-04 | — | — | US | claimed |
| US-6235753-B1 | TUMOR NECROSIS FACTOR; AUTOIMMUNE DISEASES; ANTIALLERGENS | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-05-22 | — | — | US | claimed |
| WO-2001027102-A1 | SUBSTITUTED DIAZEPANES | NOVARTIS AG (CH) | 2001-04-19 | — | — | WO | claimed |
| US-5107062-A | Selective adsorption, cation exchanging | UOP (US) | 1992-04-21 | — | — | US | claimed |
| EP-0192492-B1 | PEPTIDES CONTAINING AN ALIPHATIC-AROMATIC KETONE SIDE CHAIN | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1992-01-02 | — | — | EP | claimed |
| US-5073654-A | Catalyzing in presence of zeolite type beta | UOP (US) | 1991-12-17 | — | — | US | claimed |
| JP-6184008-A | — | — | None | — | — | JP | disclosed |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-12414565-B2 | Pyridazine (THIO)amides as fungicidal compounds | BAYER AKTIENGESELLSCHAFT (DE) | 2025-09-16 | — | — | US | disclosed |
| US-4458047-A | HEATING WITH ACID CATALYST | SUN TECH, INC. (US) | 1984-07-03 | — | — | US | disclosed |
| US-4224458-A | Process for homogeneous hydrogenation of polycyclic aromatic hydrocarbons | ALLIED CHEMICAL CORPORATION (US) | 1980-09-23 | — | — | US | disclosed |
| US-4108963-A | SOLVENT EXTRACTION | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1978-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12414565-B2 | Pyridazine (THIO)amides as fungicidal compounds | PNPO, TPMT, BLVRB | DPP4 2100/4885NPC1 2953/4885RAB9A 1625/4885 |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | DPP4 4686/4885NPC1 3402/4885RAB9A 1741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.